Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911757002> ?p ?o ?g. }
- W2911757002 endingPage "434" @default.
- W2911757002 startingPage "424" @default.
- W2911757002 abstract "Solid malignancies are frequently infiltrated with T cells. The success of adoptive cell transfer (ACT) with expanded tumour-infiltrating lymphocytes (TILs) in melanoma warrants its testing in other cancer types. In this preclinical study, we investigated whether clinical-grade TILs could be manufactured from ovarian cancer (OC) tumour specimens. Thirty-four tumour specimens were obtained from 33 individual patients with OC. TILs were analysed for phenotype, antigen specificity and functionality. Minimally expanded TILs (Young TILs) were successfully established from all patients. Young TILs contained a high frequency of CD3+ cells with a variable CD4/CD8 ratio. TILs could be expanded to clinical numbers. Importantly, recognition of autologous tumour cells was demonstrated in TILs in >50% of the patients. We confirmed with mass spectrometry the presentation of multiple tumour antigens, including peptides derived from the cancer-testis antigen GAGE, which could be recognised by antigen-specific TILs. Antigen-specific TILs could be isolated and further expanded in vitro. These findings support the hypothesis that patients with OC can benefit from ACT with TILs and led to the initiation of a pilot clinical trial at our institution . clinicaltrials.gov: NCT02482090." @default.
- W2911757002 created "2019-02-21" @default.
- W2911757002 creator A5017724230 @default.
- W2911757002 creator A5025825017 @default.
- W2911757002 creator A5028455797 @default.
- W2911757002 creator A5033740747 @default.
- W2911757002 creator A5035335225 @default.
- W2911757002 creator A5037890060 @default.
- W2911757002 creator A5046828383 @default.
- W2911757002 creator A5047204650 @default.
- W2911757002 creator A5051043977 @default.
- W2911757002 creator A5057829284 @default.
- W2911757002 creator A5069438398 @default.
- W2911757002 creator A5087479651 @default.
- W2911757002 date "2019-02-01" @default.
- W2911757002 modified "2023-10-08" @default.
- W2911757002 title "Tumour-reactive T cell subsets in the microenvironment of ovarian cancer" @default.
- W2911757002 cites W1511171894 @default.
- W2911757002 cites W1781302273 @default.
- W2911757002 cites W1951988019 @default.
- W2911757002 cites W1981978810 @default.
- W2911757002 cites W1986215428 @default.
- W2911757002 cites W1990602451 @default.
- W2911757002 cites W1997292641 @default.
- W2911757002 cites W2011458181 @default.
- W2911757002 cites W2012670008 @default.
- W2911757002 cites W2046407551 @default.
- W2911757002 cites W2050407789 @default.
- W2911757002 cites W2052787920 @default.
- W2911757002 cites W2058899594 @default.
- W2911757002 cites W2085935150 @default.
- W2911757002 cites W2087025867 @default.
- W2911757002 cites W2097173066 @default.
- W2911757002 cites W2099842815 @default.
- W2911757002 cites W2105459360 @default.
- W2911757002 cites W2107321795 @default.
- W2911757002 cites W2113847305 @default.
- W2911757002 cites W2131473264 @default.
- W2911757002 cites W2137074525 @default.
- W2911757002 cites W2141269240 @default.
- W2911757002 cites W2144063266 @default.
- W2911757002 cites W2147622445 @default.
- W2911757002 cites W2152061559 @default.
- W2911757002 cites W2154175915 @default.
- W2911757002 cites W2155959680 @default.
- W2911757002 cites W2165431330 @default.
- W2911757002 cites W2170069893 @default.
- W2911757002 cites W2309691699 @default.
- W2911757002 cites W2311929452 @default.
- W2911757002 cites W2314266201 @default.
- W2911757002 cites W2344919561 @default.
- W2911757002 cites W2345351072 @default.
- W2911757002 cites W2403289604 @default.
- W2911757002 cites W2509057906 @default.
- W2911757002 cites W2515679040 @default.
- W2911757002 cites W2782496117 @default.
- W2911757002 cites W2792236348 @default.
- W2911757002 cites W2793742921 @default.
- W2911757002 cites W2884409866 @default.
- W2911757002 doi "https://doi.org/10.1038/s41416-019-0384-y" @default.
- W2911757002 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6461863" @default.
- W2911757002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30718808" @default.
- W2911757002 hasPublicationYear "2019" @default.
- W2911757002 type Work @default.
- W2911757002 sameAs 2911757002 @default.
- W2911757002 citedByCount "43" @default.
- W2911757002 countsByYear W29117570022019 @default.
- W2911757002 countsByYear W29117570022020 @default.
- W2911757002 countsByYear W29117570022021 @default.
- W2911757002 countsByYear W29117570022022 @default.
- W2911757002 countsByYear W29117570022023 @default.
- W2911757002 crossrefType "journal-article" @default.
- W2911757002 hasAuthorship W2911757002A5017724230 @default.
- W2911757002 hasAuthorship W2911757002A5025825017 @default.
- W2911757002 hasAuthorship W2911757002A5028455797 @default.
- W2911757002 hasAuthorship W2911757002A5033740747 @default.
- W2911757002 hasAuthorship W2911757002A5035335225 @default.
- W2911757002 hasAuthorship W2911757002A5037890060 @default.
- W2911757002 hasAuthorship W2911757002A5046828383 @default.
- W2911757002 hasAuthorship W2911757002A5047204650 @default.
- W2911757002 hasAuthorship W2911757002A5051043977 @default.
- W2911757002 hasAuthorship W2911757002A5057829284 @default.
- W2911757002 hasAuthorship W2911757002A5069438398 @default.
- W2911757002 hasAuthorship W2911757002A5087479651 @default.
- W2911757002 hasBestOaLocation W29117570021 @default.
- W2911757002 hasConcept C121608353 @default.
- W2911757002 hasConcept C126322002 @default.
- W2911757002 hasConcept C143998085 @default.
- W2911757002 hasConcept C147483822 @default.
- W2911757002 hasConcept C167672396 @default.
- W2911757002 hasConcept C203014093 @default.
- W2911757002 hasConcept C2776090121 @default.
- W2911757002 hasConcept C2777658100 @default.
- W2911757002 hasConcept C2778326572 @default.
- W2911757002 hasConcept C2780427987 @default.
- W2911757002 hasConcept C502942594 @default.
- W2911757002 hasConcept C71924100 @default.
- W2911757002 hasConcept C8891405 @default.